VYNE Therapeutics (VYNE) Net Margin Growth (1y) (2018 - 2025)
VYNE Therapeutics (VYNE) Net Margin Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -244.00 |
| Mar 31, 2025 | 400.00 |
| Dec 31, 2024 | 3,773.00 |
| Jun 30, 2024 | 1,444.00 |
| Mar 31, 2024 | 200.00 |
| Dec 31, 2023 | 748,367.00 |
| Sep 30, 2023 | -32,784.00 |
| Jun 30, 2023 | 17,127.00 |
| Mar 31, 2023 | -751,787.00 |
| Dec 31, 2022 | -635,961.00 |
| Sep 30, 2022 | 514,777.00 |
| Jun 30, 2022 | 294,059.00 |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | -63,057.00 |
| Sep 30, 2021 | -451,391.00 |
| Jun 30, 2021 | -169,928.00 |
| Mar 31, 2021 | -190,706.00 |
| Dec 31, 2020 | 1.54 Mn |
| Mar 31, 2020 | 382,857.00 |
| Dec 31, 2019 | -1.62 Mn |